Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Bone Neoplasms × Biopsy, Needle × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Carcinoma, Intraductal, Noninfiltrating 1 Bone Neoplasms 1

Interventions

Irinotecan 2 Cyclophosphamide 2 tocilizumab 1 poly ICLC 1 pembrolizumab 1 palbociclib 1 liposomal doxorubicin 1 fludarabine 1 flt3 ligand protein 1 aldesleukin 1 Topotecan 1 Temozolomide 1 Taxes 1 Radiotherapy 1 Radiosurgery 1 Radiation 1 Paclitaxel 1 Observation 1 Nivolumab 1 Lomustine 1 Ipilimumab 1 Gemcitabine 1 Fitness Trackers 1 Doxorubicin 1 Carboplatin 1 CTLA-4 Antigen 1 Biopsy, Needle 1 Albumin-Bound Paclitaxel 1 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07113301 2025-08-08

INSPECTOR

Istituto Ortopedico Rizzoli

Active not recruiting

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡